Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 384

1.

Urinary exosomal shuttle RNA: Promising cancer diagnosis biomarkers of lower urinary tract.

De Palma G, Di Lorenzo VF, Krol S, Paradiso AV.

Int J Biol Markers. 2019 Mar 13:1724600819827023. doi: 10.1177/1724600819827023. [Epub ahead of print]

PMID:
30862241
2.

Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer.

Divella R, Mazzocca A, Daniele A, Sabbà C, Paradiso A.

Int J Biol Sci. 2019 Jan 1;15(3):610-616. doi: 10.7150/ijbs.29599. eCollection 2019. Review.

3.

The circular RNome of primary breast cancer.

Smid M, Wilting SM, Uhr K, Rodríguez-González FG, de Weerd V, Prager-Van der Smissen WJC, van der Vlugt-Daane M, van Galen A, Nik-Zainal S, Butler A, Martin S, Davies HR, Staaf J, van de Vijver MJ, Richardson AL, MacGrogan G, Salgado R, van den Eynden GGGM, Purdie CA, Thompson AM, Caldas C, Span PN, Sweep FCGJ, Simpson PT, Lakhani SR, Van Laere S, Desmedt C, Paradiso A, Eyfjord J, Broeks A, Vincent-Salomon A, Futreal AP, Knappskog S, King T, Viari A, Børresen-Dale AL, Stunnenberg HG, Stratton M, Foekens JA, Sieuwerts AM, Martens JWM.

Genome Res. 2019 Mar;29(3):356-366. doi: 10.1101/gr.238121.118. Epub 2019 Jan 28.

PMID:
30692147
4.

Aberrant miRNAs expressed in HER-2 negative breast cancers patient.

Braicu C, Raduly L, Morar-Bolba G, Cojocneanu R, Jurj A, Pop LA, Pileczki V, Ciocan C, Moldovan A, Irimie A, Eniu A, Achimas-Cadariu P, Paradiso A, Berindan-Neagoe I.

J Exp Clin Cancer Res. 2018 Oct 20;37(1):257. doi: 10.1186/s13046-018-0920-2.

5.

Effect of cerium on growth and antioxidant metabolism of Lemna minor L.

Zicari MA, d'Aquino L, Paradiso A, Mastrolitti S, Tommasi F.

Ecotoxicol Environ Saf. 2018 Nov 15;163:536-543. doi: 10.1016/j.ecoenv.2018.07.113. Epub 2018 Aug 1.

PMID:
30077150
6.

PARP Inhibitors in Breast Cancer: Why, How, and When?

Paradiso A, Andreopoulou E, Conte P, Eniu A, Saghatchian M.

Breast Care (Basel). 2018 Jul;13(3):216-219. doi: 10.1159/000490746. Epub 2018 Jun 20. No abstract available.

7.

Biobanks and scientists: supply and demand.

Paradiso AV, Daidone MG, Canzonieri V, Zito A.

J Transl Med. 2018 May 22;16(1):136. doi: 10.1186/s12967-018-1505-8.

8.

Adipokines in hereditary breast cancer patients and healthy relatives.

Sambiasi D, De Summa S, Digennaro M, Pilato B, Paradiso A, Tommasi S.

Oncotarget. 2017 Sep 18;8(60):101255-101261. doi: 10.18632/oncotarget.21018. eCollection 2017 Nov 24.

9.

Genetic alterations in sporadic triple negative breast cancer.

Pop LA, Cojocneanu-Petric RM, Pileczki V, Morar-Bolba G, Irimie A, Lazar V, Lombardo C, Paradiso A, Berindan-Neagoe I.

Breast. 2018 Apr;38:30-38. doi: 10.1016/j.breast.2017.11.006. Epub 2017 Dec 5.

PMID:
29202330
10.

VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients.

Schirosi L, De Summa S, Tommasi S, Paradiso A, Gasparini G, Popescu O, Simone G, Mangia A.

Int J Cancer. 2017 Nov 1;141(9):1901-1911. doi: 10.1002/ijc.30868. Epub 2017 Jul 20.

11.

Cross-cultural validation of health literacy measurement tools in Italian oncology patients.

Zotti P, Cocchi S, Polesel J, Cipolat Mis C, Bragatto D, Cavuto S, Conficconi A, Costanzo C, De Giorgi M, Drace CA, Fiorini F, Gangeri L, Lisi A, Martino R, Mosconi P, Paradiso A, Ravaioli V, Truccolo I, De Paoli P; ICPEG.

BMC Health Serv Res. 2017 Jun 19;17(1):410. doi: 10.1186/s12913-017-2359-0.

12.

Therapeutic Strategies in Triple-Negative Breast Cancer.

Paradiso A, Singer CF.

Breast Care (Basel). 2017 Mar;12(1):6-7. doi: 10.1159/000460238. Epub 2017 Feb 28. No abstract available.

13.

Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites.

Digennaro M, Sambiasi D, Tommasi S, Pilato B, Diotaiuti S, Kardhashi A, Trojano G, Tufaro A, Paradiso AV.

Hered Cancer Clin Pract. 2017 May 25;15:7. doi: 10.1186/s13053-017-0067-8. eCollection 2017.

14.

Minimally invasive heart valve surgery: influence on coagulation and inflammatory response.

Paparella D, Rotunno C, Guida P, Travascia M, De Palo M, Paradiso A, Carrozzo A, Rociola R.

Interact Cardiovasc Thorac Surg. 2017 Aug 1;25(2):225-232. doi: 10.1093/icvts/ivx090.

PMID:
28481998
15.

Comment on 'Renewed interest in the progesterone receptor in breast cancer'.

Simone G, Diotaiuti S, Digennaro M, Sambiasi D, De Summa S, Tommasi S, Altieri R, Mangia A, Dantona C, Paradiso A.

Br J Cancer. 2017 Jul 11;117(2):e1. doi: 10.1038/bjc.2017.90. Epub 2017 Apr 11. No abstract available.

16.

ROS Production and Scavenging under Anoxia and Re-Oxygenation in Arabidopsis Cells: A Balance between Redox Signaling and Impairment.

Paradiso A, Caretto S, Leone A, Bove A, Nisi R, De Gara L.

Front Plant Sci. 2016 Dec 1;7:1803. eCollection 2016.

17.

Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy.

Braicu C, Chiorean R, Irimie A, Chira S, Tomuleasa C, Neagoe E, Paradiso A, Achimas-Cadariu P, Lazar V, Berindan-Neagoe I.

Expert Rev Mol Med. 2016 Nov 7;18:e18. Review.

PMID:
27817751
18.

Glutamine synthetase in Durum Wheat: Genotypic Variation and Relationship with Grain Protein Content.

Nigro D, Fortunato S, Giove SL, Paradiso A, Gu YQ, Blanco A, de Pinto MC, Gadaleta A.

Front Plant Sci. 2016 Jul 13;7:971. doi: 10.3389/fpls.2016.00971. eCollection 2016.

19.

Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy.

Gennari A, Amadori D, Scarpi E, Farolfi A, Paradiso A, Mangia A, Biglia N, Gianni L, Tienghi A, Rocca A, Maltoni R, Antonucci G, Bruzzi P, Nanni O.

Breast Cancer Res Treat. 2016 Aug;159(1):79-86. doi: 10.1007/s10549-016-3923-8. Epub 2016 Jul 26.

PMID:
27460638
20.

Comment on 'The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study'.

Paradiso AV, Digennaro M, Sambiasi D.

Br J Cancer. 2016 Aug 23;115(5):e3. doi: 10.1038/bjc.2016.224. Epub 2016 Jul 26. No abstract available.

21.

BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report.

Pilato B, Pinto R, De Summa S, Petriella D, Lacalamita R, Danza K, Paradiso A, Tommasi S.

Genes Chromosomes Cancer. 2016 Oct;55(10):803-13. doi: 10.1002/gcc.22383. Epub 2016 Jul 4.

PMID:
27225819
22.

Participation of Italian Cancer Centres of the Alleanza Contro Il Cancro (ACC) in the Organisation of European Cancer Institutes (OECI) Accreditation and Designation program: a successful first national initiative.

Oberst S, Boomsma F, Lombardo C, Docter M, Blaauwgeers H, De Paoli P, de Valeriola D, Paradiso A, Saghatchian M.

Tumori. 2015;101 Suppl 1:S6-9. doi: 10.5301/tj.5000464. Epub 2015 Dec 30.

PMID:
27098181
23.

The European accreditation of Istituto Tumori Giovanni Paolo II of Bari.

Lacalamita R, Quaranta A, Trisorio Liuzzi MP, Nigro A, Simonetti U, Schirone M, Aloè F, Capochiani G, De Francesco G, Gadaleta C, Galetta D, Grammatica L, Guarini A, Mattioli V, Milella P, Moschetta A, Nardulli P, Nigro V, Silvestris N, Paradiso A.

Tumori. 2015;101 Suppl 1:S14-8. doi: 10.5301/tj.5000467. Epub 2015 Dec 30.

PMID:
27096266
24.
25.

International Accreditation of Cancer Centres of Italian Network of Alleanza contro il Cancro: introductory remarks.

Paradiso A, Belardelli F, De Paoli P, De Maria R.

Tumori. 2015;101 Suppl 1:1. doi: 10.5301/tj.5000454. Epub 2015 Dec 30. No abstract available.

PMID:
27096263
26.

Cyclic AMP deficiency negatively affects cell growth and enhances stress-related responses in tobacco Bright Yellow-2 cells.

Sabetta W, Vannini C, Sgobba A, Marsoni M, Paradiso A, Ortolani F, Bracale M, Viggiano L, Blanco E, de Pinto MC.

Plant Mol Biol. 2016 Mar;90(4-5):467-83. doi: 10.1007/s11103-016-0431-5. Epub 2016 Jan 19.

PMID:
26786166
27.

Immunoprofile from tissue microarrays to stratify familial breast cancer patients.

Schirosi L, De Summa S, Tommasi S, Paradiso A, Sambiasi D, Popescu O, Simone G, Mangia A.

Oncotarget. 2015 Sep 29;6(29):27865-79. doi: 10.18632/oncotarget.4720.

28.

Is precision medicine the route to a healthy world?

Horgan D, Paradiso A, McVie G, Banks I, Van der Wal T, Brand A, Lawler M.

Lancet. 2015 Jul 25;386(9991):336-7. doi: 10.1016/S0140-6736(15)61404-0. No abstract available.

PMID:
26227461
29.

Making patient centered care a reality: a survey of patient educational programs in Italian Cancer Research and Care Institutes.

Cipolat Mis C, Truccolo I, Ravaioli V, Cocchi S, Gangeri L, Mosconi P, Drace C, Pomicino L, Paradiso A, De Paoli P; Italian Cancer Patient Education Group.

BMC Health Serv Res. 2015 Jul 30;15:298. doi: 10.1186/s12913-015-0962-5.

30.

Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer.

Farolfi A, Scarpi E, Rocca A, Mangia A, Biglia N, Gianni L, Tienghi A, Valerio MR, Gasparini G, Amaducci L, Faedi M, Baldini E, Rubagotti A, Maltoni R, Paradiso A, Amadori D.

Eur J Cancer. 2015 Sep;51(14):1874-81. doi: 10.1016/j.ejca.2015.07.003. Epub 2015 Jul 20.

PMID:
26206258
31.

Role of redox homeostasis in thermo-tolerance under a climate change scenario.

de Pinto MC, Locato V, Paradiso A, De Gara L.

Ann Bot. 2015 Sep;116(4):487-96. doi: 10.1093/aob/mcv071. Epub 2015 May 31. Review.

32.

Phenols and antioxidant activity in vitro and in vivo of aqueous extracts obtained by ultrasound-assisted extraction from artichoke by-products.

Punzi R, Paradiso A, Fasciano C, Trani A, Faccia M, de Pinto MC, Gambacorta G.

Nat Prod Commun. 2014 Sep;9(9):1315-8.

PMID:
25918801
33.

Fructan biosynthesis and degradation as part of plant metabolism controlling sugar fluxes during durum wheat kernel maturation.

Cimini S, Locato V, Vergauwen R, Paradiso A, Cecchini C, Vandenpoel L, Verspreet J, Courtin CM, D'Egidio MG, Van den Ende W, De Gara L.

Front Plant Sci. 2015 Feb 20;6:89. doi: 10.3389/fpls.2015.00089. eCollection 2015.

34.

Involvement of DNA methylation in the control of cell growth during heat stress in tobacco BY-2 cells.

Centomani I, Sgobba A, D'Addabbo P, Dipierro N, Paradiso A, De Gara L, Dipierro S, Viggiano L, de Pinto MC.

Protoplasma. 2015 Nov;252(6):1451-9. doi: 10.1007/s00709-015-0772-y. Epub 2015 Feb 25.

PMID:
25712591
35.

The scaffolding protein NHERF1 sensitizes EGFR-dependent tumor growth, motility and invadopodia function to gefitinib treatment in breast cancer cells.

Bellizzi A, Greco MR, Rubino R, Paradiso A, Forciniti S, Zeeberg K, Cardone RA, Reshkin SJ.

Int J Oncol. 2015 Mar;46(3):1214-24. doi: 10.3892/ijo.2014.2805. Epub 2014 Dec 19.

PMID:
25530180
36.

KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer.

Xu JM, Liu XJ, Ge FJ, Lin L, Wang Y, Sharma MR, Liu ZY, Tommasi S, Paradiso A.

J Exp Clin Cancer Res. 2014 Dec 10;33:104. doi: 10.1186/s13046-014-0104-7.

37.

The EGFR pathway regulates BCRP expression in NSCLC cells: role of erlotinib.

Porcelli L, Giovannetti E, Assaraf YG, Jansen G, Scheffer GL, Kathman I, Azzariti A, Paradiso A, Peters GJ.

Curr Drug Targets. 2014;15(14):1322-30.

PMID:
25479544
38.

Sister chromatid exchange: A possible approach to characterize familial breast cancer patients.

De Pascalis I, Pilato B, Mazzotta A, Dell'Endice TS, Rubini V, Simone G, Paradiso A, Aiello V, Mangia A.

Oncol Rep. 2015 Feb;33(2):930-4. doi: 10.3892/or.2014.3628. Epub 2014 Nov 26.

PMID:
25434423
39.

Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patients.

Danza K, De Summa S, Pilato B, Carella M, Palumbo O, Popescu O, Paradiso A, Pinto R, Tommasi S.

J Transl Med. 2014 Nov 19;12:319. doi: 10.1186/s12967-014-0319-6.

40.

MicroRNA expression profiling in male and female familial breast cancer.

Pinto R, De Summa S, Danza K, Popescu O, Paradiso A, Micale L, Merla G, Palumbo O, Carella M, Tommasi S.

Br J Cancer. 2014 Dec 9;111(12):2361-8. doi: 10.1038/bjc.2014.535. Epub 2014 Nov 13.

41.

CES2, ABCG2, TS and Topo-I primary and synchronous metastasis expression and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI regimen.

Silvestris N, Simone G, Partipilo G, Scarpi E, Lorusso V, Brunetti AE, Maiello E, Paradiso A, Mangia A.

Int J Mol Sci. 2014 Sep 5;15(9):15767-77. doi: 10.3390/ijms150915767.

42.

Pulsed Light Accelerated Crosslinking versus Continuous Light Accelerated Crosslinking: One-Year Results.

Mazzotta C, Traversi C, Paradiso AL, Latronico ME, Rechichi M.

J Ophthalmol. 2014;2014:604731. doi: 10.1155/2014/604731. Epub 2014 Aug 3.

43.

The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.

Saponaro C, Malfettone A, Dell'Endice TS, Brunetti AE, Achimas-Cadariu P, Paradiso A, Mangia A.

Cancer Biomark. 2014;14(2-3):177-84. doi: 10.3233/CBM-130329. Review.

PMID:
24878819
44.

Is there a role of Eastern Europe in cancer biomarkers for personalized cancer medicine?

Berindan-Neagoe I, Paradiso A.

Cancer Biomark. 2014;14(2-3):85-6. doi: 10.3233/CBM-130342. No abstract available.

PMID:
24878808
45.

Rare disease research: Breaking the privacy barrier.

Mascalzoni D, Paradiso A, Hansson M.

Appl Transl Genom. 2014 Apr 18;3(2):23-9. doi: 10.1016/j.atg.2014.04.003. eCollection 2014 Jun 1.

46.

Changes in antioxidants are critical in determining cell responses to short- and long-term heat stress.

Sgobba A, Paradiso A, Dipierro S, De Gara L, de Pinto MC.

Physiol Plant. 2015 Jan;153(1):68-78. doi: 10.1111/ppl.12220. Epub 2014 May 31.

PMID:
24796393
47.

Mitochondrial DNA variants and risk of familial breast cancer: an exploratory study.

Tommasi S, Favia P, Weigl S, Bianco A, Pilato B, Russo L, Paradiso A, Petruzzella V.

Int J Oncol. 2014 May;44(5):1691-8. doi: 10.3892/ijo.2014.2324. Epub 2014 Mar 5.

PMID:
24603941
48.

Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment.

Ranieri G, Marech I, Lorusso V, Goffredo V, Paradiso A, Ribatti D, Gadaleta CD.

World J Gastroenterol. 2014 Jan 14;20(2):486-97. doi: 10.3748/wjg.v20.i2.486. Review.

49.

Expression of base excision repair key factors and miR17 in familial and sporadic breast cancer.

De Summa S, Pinto R, Pilato B, Sambiasi D, Porcelli L, Guida G, Mattioli E, Paradiso A, Merla G, Micale L, De Nittis P, Tommasi S.

Cell Death Dis. 2014 Feb 20;5:e1076. doi: 10.1038/cddis.2014.30.

50.

Accreditation for excellence of cancer research institutes: recommendations from the Italian Network of Comprehensive Cancer Centers.

Deriu PL, La Pietra L, Pierotti M, Collazzo R, Paradiso A, Belardelli F, De Paoli P, Nigro A, Lacalamita R, Ferrarini M, Pelicci P, Pierotti M, Roli A, Ciliberto G, Scala S, Amadori A, Chiusole D, Musto P, Fusco V, Storto G, De Maria R, Canitano S, Apolone G, Ravelli M, Mazzini E, Amadori D, Bernabini M, Ancarani V, Lombardo C.

Tumori. 2013 Nov-Dec;99(6):293e-8e. doi: 10.1700/1390.15472.

Supplemental Content

Loading ...
Support Center